Benjamin Bearnot, MD
Benjamin Bearnot, MD received medical degree from New York University, did residency training in internal medicine and primary care at MGH, and completed a Masters in Public Health at the Harvard Chan School of Public Health.
Dr. Bearnot’s early clinical research focused on the interrelated HIV and tuberculosis epidemics in sub-Saharan Africa and HIV at-risk populations domestically, and he received a Fulbright-Fogarty fellowship in public health to further his work in Durban, South Africa. He has now shifted his research and implementation science focus to addressing the devastating addiction and drug overdose epidemics facing the United States. He was the recipient of the Best Overall Abstract Award at the 2018 American Society of Addiction Medicine national conference, the Best Oral Abstract Award at the 2018 New England Regional Society of General Internal Medicine conference, and the Young Investigator Honorable Mention at the 2019 American Society of Addiction Medicine national conference.
His K12 project involves feasibility of enrolling a population of individuals with opioid use disorder (OUD) and serious bacterial infections (SBI) in a prospective cohort, observing clinical and substance use disorder (SUD) outcomes in the cohort, and exploring the potential to use medication for opioid use disorder (MOUD) to improve outcomes in this population.